Potential Role of Pleural Fluid Cytokine Profile in Myelomatous Pleural Effusions
Junhui Xu,Liang Gao,Miao Yan,Bingjie Wang,Zheng-yang Song,Huihui Liu,Kunyan Sun,Lin Nong,Mangju Wang,Xinan Cen
DOI: https://doi.org/10.2147/OTT.S324810
IF: 4
2021-08-24
OncoTargets and Therapy
Abstract:Junhui Xu, 1, 2, &ast Liang Gao, 1, &ast Miao Yan, 1 Bingjie Wang, 1 Zhengyang Song, 1 Huihui Liu, 1 Kunyan Sun, 3 Lin Nong, 4 Mangju Wang, 1 Xinan Cen 1 1 Department of Hematology, Peking University First Hospital, Beijing, People's Republic of China; 2 Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, People's Republic of China; 3 Department of Respiration, Peking University First Hospital, Beijing, People's Republic of China; 4 Department of Pathology, Peking University First Hospital, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mangju Wang; Xinan Cen Department of Hematology, Peking University First Hospital, No. 8 Xi Shi Ku Street, Xi Cheng District, Beijing, 100034, People's Republic of China Tel +86-10-83575746 Email ; Background: Myelomatous pleural effusion (MPE), as a presentation of extramedullary infiltration of multiple myeloma (MM), is rare and currently associated with poor outcomes without effective therapy. The potential value of cytokine detection in pleural effusion to MPE has not been reported to date. Case Presentation: We herein report a case of refractory and relapsed multiple myeloma that developed bilateral MPE due to disease progression caused by intolerance to various chemotherapy regimens. Cytomorphology and flow cytometry were adopted for diagnosis confirmation. Chemotherapy containing immunomodulators combined with thoracic catheterization drainage was applied to the patient, showing a certain therapeutic effect. During the course of disease, the change of cytokine profile in pleural effusion was monitored by cytometric bead array (CBA) technology, revealing that cytokines related to tumor load such as interleukin 6 (IL-6) and interleukin 10 (IL-10) in pleural effusion decreased with the improvement of disease, while other cytokines such as interleukin 2 (IL-2), interleukin 4 (IL-4), interleukin 17A (IL-17A), tumor necrosis factor α (TNF-α), interferon γ (IFN-γ), granzyme A, granzyme B, perforin and granulysin increased with the improvement of disease. Conclusion: There is a prospect that cytokine level in pleural effusion may indicate treatment response of MPE, and in light of this case, immunomodulators may be utilized in treating patients suffering MPE. Due to limitations of our single case, we urge more groups to evaluate the potential role of cytokine profile in MPE. Keywords: myelomatous pleural effusions, cytokine, IFN-γ, IL-2, immunomodulator MM is characterized by abnormal proliferation of monoclonal plasma cells secreting large amounts of monoclonal immunoglobulin or light chains inside bone marrow and finally leads to anemia, hypercalcemia, bone destruction, kidney injury, etc. Incidence of pleural effusion in MM patients is approximately 6%, 1 and the possible mechanisms include hypoalbuminemia, congestive heart failure caused by amyloidosis cardiomyopathy, renal dysfunction, pleural invasion, etc. 2 Among them, we name the pleural effusion caused by pleural invasion as MPE, which is a type of extramedullary invasion with poor prognosis and treatment response. 1 Other than tuberculous pleural effusion, a high level of adenosine deaminase (ADA) was also reported in one-third of MPE, which indicates MPE patients' varied immunocompetence based on ADA's important role in lymphatic system differentiation and maturation. 3 In some cases, reports of chemotherapy combined with intrathoracic injection of IL-2 or interferon α (IFN-α) attained a proven curative effect, achieving a remission duration of up to 30 months. 4,5 All these phenomena imply that the immune system plays an important role in the development of MPE. We applied CBA technology (LEGENDplexTM Human CD8/NK Panel) to monitor cytokine profile in pleural effusion to explore the important role of cytokines during the disease course of an MPE patient. The LEGENDplexTM Human CD8/NK Panel (Biolegend, cat.740267) is a multiplex bead-based assay, using fluorescence-encoded beads suitable for use on various flow cytometers. This panel allows simultaneous quantification of 13 human proteins with high detection sensitivities and broad dynamic ranges, including IL-2, IL-4, IL-10, IL-6, IL-17A, TNF-α, soluble Fas (sFas), soluble Fas Ligand (sFasL), IFN-γ, granzyme A, granzyme B, perforin and granulysin. The patient was a 70-year-old female who visited Beijing Hospital in 2014 for weakness, amaurosis and profuse sweating. The hemoglobin concentration was 63g/L (6.3g/dL). The white blood cell count was 6.49×10 9 /L. The platelet count was -Abstract Truncated-
oncology,biotechnology & applied microbiology